 Connection
Aravindhan Veerapandiyan to United States
This is a "connection" page, showing publications Aravindhan Veerapandiyan has written about United States.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.235 |
|
|
|
-
Grabich S, Ung B, Nadkar A, DeYoung K, Signorovitch J, Veerapandiyan A. Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis. J Comp Eff Res. 2025 Aug; 14(8):e250037.
Score: 0.106
-
Ranabothu S, Onteddu S, Nalleballe K, Dandu V, Veerapaneni K, Veerapandiyan A. Spectrum of COVID-19 in children. Acta Paediatr. 2020 09; 109(9):1899-1900.
Score: 0.075
-
Tian C, Grabich S, Veerapandiyan A, Scharf RJ, Santra S, Hornibrook S, Drummond K, Sehinovych I, Waldrop M. Advancements from the EVOLVE study for assessing real-world experience with eteplirsen, golodirsen and casimersen for the treatment of DMD. J Comp Eff Res. 2026 May; 15(5):e250108.
Score: 0.028
-
Baldi O, Kinnett K, Schrader R, Denger B, Truba N, Sorensen S, Veerapandiyan A, Colvin MK. Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy. Muscle Nerve. 2025 Mar; 71(3):377-383.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|